Personal profile


Our group focuses on peptide-based drug design, membrane biology and biomaterials. We are developing novel compounds that allow us to exploit the potential of peptides as drugs and are currently applying our technology to new compounds for treatments of cardiovascular disease. Our membrane biology projects involve the development of new methods for membrane protein analysis with application to apoptosis, G protein-coupled receptor function and antimicrobial peptide function. We are also applying our recently developed peptide-based materials to the development of new scaffolds for stem cell growth and tissue regeneration.

The long-term aim of these studies is to increase our understanding of the molecular basis of peptide and protein function and allow the rational design of peptide and protein based therapeutics.


  • Peptides
  • Biomembranes
  • Peptide Drugs
  • Bionanotechnology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2020

Research Output 1987 2017

Quantitative Detection of Weak D Antigen Variants in Blood Typing using SPR

Then, W. L., Aguilar, M-I. & Garnier, G. 1 Dec 2017 In : Scientific Reports. 7, 1, 7 p., 1616

Research output: Research - peer-reviewArticle

Open Access
Open Access